Q3FY17 Results: Shilpa Medicare
On Tuesday, Shilpa Medicare Ltd. reported its consolidated results for the quarter ended on December 31, 2016.
The company's sales for this quarter, Q3FY17, came in at Rs 183.5 crore. This represents a 13.12 per cent sequential decline and 8.25 per cent YoY decline. Its operating profit (EBIT) for the recently concluded quarter amounted to Rs 27 crore and the EBIT margin stood at 14.71 per cent. In terms of the bottom-line, the company reported a PAT figure of Rs 20.7 crore, which represents a sequential QoQ decline of 35.51 per cent and a YoY decline of 31.91 per cent.
Technical Levels for Shipla Medicare
Support at 640 and Resistance at 740
Looks weak and could touch its support level of 640 , below 640 will take it to 600—580 else could touch its resistance level of 740 again.
More will update soon!!
